|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-7-7
|
|
pubmed:abstractText |
The aim of this study was to assess the efficacy and safety of esomeprazole 40 mg once daily (q.d.) in healing reflux oesophagitis at 4 and 8 weeks, and the efficacy of esomeprazole 20 mg q.d. for 12 weeks in the maintenance of remission.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
T
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0741-238X
|
|
pubmed:author |
pubmed-author:AtugOzlenO,
pubmed-author:DolarEnverE,
pubmed-author:GiralAdnanA,
pubmed-author:IsitanFahriF,
pubmed-author:KalayciCemC,
pubmed-author:OguzDilekD,
pubmed-author:OvuncOyaO,
pubmed-author:OzgurOrhanO,
pubmed-author:SimsekIlkayI,
pubmed-author:SoykanIrfanI,
pubmed-author:Turkish HEMANEX Study Group,
pubmed-author:UnalSelahattinS,
pubmed-author:YeniceNecatiN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
552-66
|
|
pubmed:meshHeading |
pubmed-meshheading:18568450-Adolescent,
pubmed-meshheading:18568450-Adult,
pubmed-meshheading:18568450-Aged,
pubmed-meshheading:18568450-Anti-Ulcer Agents,
pubmed-meshheading:18568450-Drug Administration Schedule,
pubmed-meshheading:18568450-Endoscopy, Digestive System,
pubmed-meshheading:18568450-Esophagitis, Peptic,
pubmed-meshheading:18568450-Female,
pubmed-meshheading:18568450-Humans,
pubmed-meshheading:18568450-Male,
pubmed-meshheading:18568450-Middle Aged,
pubmed-meshheading:18568450-Omeprazole,
pubmed-meshheading:18568450-Patient Satisfaction,
pubmed-meshheading:18568450-Prospective Studies,
pubmed-meshheading:18568450-Young Adult
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Esomeprazole in acute and maintenance treatment of reflux oesophagitis: a multicentre prospective study.
|
|
pubmed:affiliation |
School of Medicine, Department of Gastroenterology, Marmara University, Istanbul, Turkey.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
